Study Stopped
Difficulties with including patients
Exercise Therapy With Risk Factor Management and Life Style Coaching After Vascular Intervention for Patients With Peripheral Arterial Disease
PEARL
1 other identifier
interventional
14
1 country
2
Brief Summary
Patients with peripheral arterial disease with symptoms of critical ischemia or reduced tissue loss have a very high mortality and morbidity rate. So far, treatment strategies focused on the preservation of life and limb by an open surgical or endovascular revascularization, together with cardiovascular risk management and pain relief. Important modifiable factors related to mortality and morbidity are not covered in the current national and international guidelines. This study investigates the effects on mobility, mortality and quality of life with supplementation of the standard treatment of critical limb ischemia with supervised exercise therapy. Also a reduction of cardiovascular risk by intensive risk factor management and lifestyle coaching will be taken in to account. The supervised exercise therapy will take place under the supervision of a trained physiotherapist.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2011
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2011
CompletedFirst Submitted
Initial submission to the registry
April 1, 2014
CompletedFirst Posted
Study publicly available on registry
April 10, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2014
CompletedJuly 25, 2019
July 1, 2019
2.9 years
April 1, 2014
July 23, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Mobility
Pain free walking distance WIQ ALDS
2 years
Secondary Outcomes (2)
Quality of life
2 years
Mortality
2 years
Study Arms (2)
Supervised exercise therapy
EXPERIMENTALAdequacy of initial therapy, Investigation degree of confusion and dementia, Preoperative preparation, Life-style coaching, Supervised Exercise therapy.
Walking advice
NO INTERVENTIONStandard care and a oral walking advice.
Interventions
Eligibility Criteria
You may qualify if:
- Patients with peripheral arterial disease Rutherford stage 4 and 5, where it is possible to improve the vascularization of the affected leg with the help of an endovascular and / or open surgical vascular intervention.
- Patients with both legs are affected, but the most severe leg does not exceed stage 5.
You may not qualify if:
- Severe cardiopulmonary comorbidity (NYHA 4) and previous amputations of lower leg or thigh.
- Patients with limited amputation of the toes can participate.
- Insufficient understanding of the Dutch language.
- No physiotherapy insurance.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Catharina Ziekenhuis
Eindhoven, North Brabant, 5623 EJ, Netherlands
Medisch Centrum Alkmaar
Alkmaar, 1815 JD, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joep Teijink, prof. dr.
Catharina Ziekenhuis Eindhoven
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- prof. dr.
Study Record Dates
First Submitted
April 1, 2014
First Posted
April 10, 2014
Study Start
September 1, 2011
Primary Completion
August 1, 2014
Study Completion
August 1, 2014
Last Updated
July 25, 2019
Record last verified: 2019-07